Results for “Moderna”
48 stories found

Latvian Farm 'Silmalas' Transforms from Five Cows to Robotic Dairy
The 'Silmalas' farm in Krimulda parish, Latvia, has evolved from a small operation with five cows to a modern facility housing 160 cows milked by three robotic systems, continuing a family legacy.
Moderna’s Covid-Flu Vaccine Recommended for Approval in EU - WSJ
Moderna’s Covid-Flu Vaccine Recommended for Approval in EU WSJ
La galería Artur Ramon rescata la cerámica moderna de Antoni Cumella
El espacio acoge la exposición ‘Antoni Cumella. Arquitectura de las formas‘, que pone en valor la obra del gran maestro de la cerámica
90th Anniversary of Charlie Chaplin's 'Modern Times'
The film 'Modern Times' (1936) is celebrated on its 90th anniversary, marking the final appearance of Charlie Chaplin's beloved character, 'The Tramp'.
Chronic Inflammation and Turmeric's Role in Modern Diseases
A new report highlights chronic inflammation as a fundamental cause of modern diseases, with current evidence analyzing turmeric's role in chronic inflammation, cognitive, and cardiovascular health, while technological innovation seeks to improve its absorption and real efficacy.
What’s News in Markets: Walmart Slumps, Omnicom Rallies, Moderna Comeback - What’s News - WSJ Podcasts - The Wall Street Journal
What’s News in Markets: Walmart Slumps, Omnicom Rallies, Moderna Comeback - What’s News - WSJ Podcasts The Wall Street Journal
What’s News in Markets: Walmart Slumps, Omnicom Rallies, Moderna Comeback - What’s News - WSJ Podcasts - The Wall Street Journal
What’s News in Markets: Walmart Slumps, Omnicom Rallies, Moderna Comeback - What’s News - WSJ Podcasts The Wall Street Journal
What’s News in Markets: Walmart Slumps, Omnicom Rallies, Moderna Comeback - What’s News - WSJ Podcasts - The Wall Street Journal
What’s News in Markets: Walmart Slumps, Omnicom Rallies, Moderna Comeback - What’s News - WSJ Podcasts The Wall Street Journal
What’s News in Markets: Walmart Slumps, Omnicom Rallies, Moderna Comeback - What’s News - WSJ Podcasts - The Wall Street Journal
What’s News in Markets: Walmart Slumps, Omnicom Rallies, Moderna Comeback - What’s News - WSJ Podcasts The Wall Street Journal
What’s News in Markets: Walmart Slumps, Omnicom Rallies, Moderna Comeback - What’s News - WSJ Podcasts - The Wall Street Journal
What’s News in Markets: Walmart Slumps, Omnicom Rallies, Moderna Comeback - What’s News - WSJ Podcasts The Wall Street Journal
La detención del expríncipe Andrés deja a la monarquía británica en estado de shock
El exduque de York se convirtió en el primer miembro de la realeza británica de la era moderna en ser arrestado por supuesta mala conducta en un cargo público
Moderna Stock Jumps on FDA Flu Vaccine Review
Moderna's stock has risen above its 20-day moving average following the FDA's review of its flu vaccine, prompting questions about its investment potential.
FDA Reverses Course and Will Now Review Moderna’s Flu Shot - The Wall Street Journal
FDA Reverses Course and Will Now Review Moderna’s Flu Shot The Wall Street Journal
Moderna Dealt Blows in Ongoing Patent Dispute with Arbutus
Moderna has faced setbacks in its ongoing patent dispute with Arbutus, indicating challenges in its intellectual property litigation.
FDA Rejection of Moderna Flu Shot Raises Questions for Vaccine Development
The Food and Drug Administration's decision to reject Moderna's new flu shot has sparked discussions about the future trajectory of vaccine innovation and approval processes.
Moderna agrees to pay up to $2.25 billion to settle COVID vaccine patent dispute
EMA Recommends Authorization for Moderna Combination COVID/Flu Vaccine
The European Medicines Agency (EMA) has recommended the authorization of Moderna's combination vaccine targeting both COVID-19 and influenza.
Moderna's Combined Covid-Flu Vaccine Recommended for Approval in EU
Moderna's vaccine combining protection against both Covid-19 and influenza has received a recommendation for approval in the European Union.

Modern Therapy for Rare Disease Available to Nine Patients in Serbia
Nine patients in Serbia with the rare Von Hippel-Lindau (VHL) syndrome have gained access to modern therapy through a donation program.
REGALADE: The Most Extensive Galaxy Catalog for Modern Astronomy Published
The REGALADE project, led by the University of Barcelona, has published the most extensive catalog of galaxies, compiling data from 80 million galaxies to enhance the precision of locating cosmic phenomena like supernovae and star mergers.
Nouvelle Vague's Influence on the Modern Woman in Cinema
In a predominantly masculine cinematic universe, the Nouvelle Vague projected a series of young actresses onto the screen, shaping the figure of the modern woman as free, independent, and seductive.
What’s News in Markets: Walmart Slumps, Omnicom Rallies, Moderna Comeback - What’s News - WSJ Podcasts - The Wall Street Journal
What’s News in Markets: Walmart Slumps, Omnicom Rallies, Moderna Comeback - What’s News - WSJ Podcasts The Wall Street Journal
What’s News in Markets: Walmart Slumps, Omnicom Rallies, Moderna Comeback - What’s News - WSJ Podcasts - The Wall Street Journal
What’s News in Markets: Walmart Slumps, Omnicom Rallies, Moderna Comeback - What’s News - WSJ Podcasts The Wall Street Journal
What’s News in Markets: Walmart Slumps, Omnicom Rallies, Moderna Comeback - What’s News - WSJ Podcasts - The Wall Street Journal
What’s News in Markets: Walmart Slumps, Omnicom Rallies, Moderna Comeback - What’s News - WSJ Podcasts The Wall Street Journal
General Market News and Company Updates
A roundup of market news includes Walmart's slump, Omnicom's rally, and Moderna's comeback, alongside a broader financial services market talk.
What’s News in Markets: Walmart Slumps, Omnicom Rallies, Moderna Comeback - What’s News - WSJ Podcasts - The Wall Street Journal
What’s News in Markets: Walmart Slumps, Omnicom Rallies, Moderna Comeback - What’s News - WSJ Podcasts The Wall Street Journal
BioNTech sues Moderna for patent infringement over COVID shots - Reuters
BioNTech sues Moderna for patent infringement over COVID shots Reuters
FDA Reverses Course and Will Now Review Moderna’s Flu Shot - The Wall Street Journal
FDA Reverses Course and Will Now Review Moderna’s Flu Shot The Wall Street Journal
Moderna Stock Rises
Moderna's stock experienced a significant increase, prompting analysis into the reasons behind its sudden pop.
Health Rounds: Moderna combo flu/COVID vaccine succeeds in mid-stage trial - Reuters
Health Rounds: Moderna combo flu/COVID vaccine succeeds in mid-stage trial Reuters

FDA Rejects Moderna's mRNA Flu Vaccine Review
The FDA has refused to review Moderna's mRNA flu vaccine, drawing widespread criticism from doctors and creating division within the agency, with Health Secretary Robert F. Kennedy Jr. broadly rejecting the technology.

Podgorica Housing Agency Continues Improvements
The Housing Agency in Podgorica is intensifying efforts to improve residential buildings and public areas, with plans for new facades, sports fields, and an outdoor gym.
Moderna Gets EU Approval for mRNA Combination Covid-Flu Shot - Bloomberg.com
Moderna Gets EU Approval for mRNA Combination Covid-Flu Shot Bloomberg.com
Moderna’s Covid-Flu Vaccine Recommended for Approval in EU - WSJ
Moderna’s Covid-Flu Vaccine Recommended for Approval in EU WSJ
Moderna's Ups and Downs: Here's What You Need to Know Before Investing.
An article provides essential information for potential investors regarding Moderna's recent performance and future prospects.
Here's Why I Wouldn't Touch Moderna With a 10‑Foot Pole Until Its Next Growth Engine Is Clear
An investor expresses strong reservations about investing in Moderna until the company's next clear growth driver is identified.
What’s News in Markets: Walmart Slumps, Omnicom Rallies, Moderna Comeback - What’s News - WSJ Podcasts - The Wall Street Journal
What’s News in Markets: Walmart Slumps, Omnicom Rallies, Moderna Comeback - What’s News - WSJ Podcasts The Wall Street Journal
What’s News in Markets: Walmart Slumps, Omnicom Rallies, Moderna Comeback - What’s News - WSJ Podcasts - The Wall Street Journal
What’s News in Markets: Walmart Slumps, Omnicom Rallies, Moderna Comeback - What’s News - WSJ Podcasts The Wall Street Journal
What’s News in Markets: Walmart Slumps, Omnicom Rallies, Moderna Comeback - What’s News - WSJ Podcasts - The Wall Street Journal
What’s News in Markets: Walmart Slumps, Omnicom Rallies, Moderna Comeback - What’s News - WSJ Podcasts The Wall Street Journal
What’s News in Markets: Walmart Slumps, Omnicom Rallies, Moderna Comeback - What’s News - WSJ Podcasts - The Wall Street Journal
What’s News in Markets: Walmart Slumps, Omnicom Rallies, Moderna Comeback - What’s News - WSJ Podcasts The Wall Street Journal
What’s News in Markets: Walmart Slumps, Omnicom Rallies, Moderna Comeback - What’s News - WSJ Podcasts - The Wall Street Journal
What’s News in Markets: Walmart Slumps, Omnicom Rallies, Moderna Comeback - What’s News - WSJ Podcasts The Wall Street Journal
Moderna Sued for Patent Infringement Related to Pfizer/BioNTech COVID-19 Vaccine
Moderna is facing a lawsuit alleging that its COVID-19 vaccine violates a patent linked to the Pfizer/BioNTech shot.

FDA Reverses Course, Agrees to Review Moderna's Flu Vaccine Application
The U.S. Food and Drug Administration has reversed its earlier decision and will now review Moderna's application for its modified influenza vaccine.
FDA Reverses Course and Will Now Review Moderna’s Flu Shot - The Wall Street Journal
FDA Reverses Course and Will Now Review Moderna’s Flu Shot The Wall Street Journal
Moderna Flu Shot Review Agreement Boosts Stock
Moderna's stock surged after the FDA reversed its stance and agreed to review the company's new flu shot.
FDA Rejects Moderna's Application for New mRNA Flu Vaccine
Moderna announced that the FDA has refused its application for a new mRNA flu vaccine.
FDA Refuses Moderna's mRNA Flu Vaccine Application
The FDA has declined to review Moderna's mRNA flu vaccine application, citing an inadequate study design, a decision the company disputes.